← Open Payments lookup

KATHERINE KOSHOFER: Open Payments

NPI 1720209935 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$555 in 40 payments from 7 companies in 2025. Trend: 2023 $700 · 2024 $623 · 2025 $555

Food & beverage: $555
CompanyPaymentsAmount
Novo Nordisk Inc22$210
Abbott Laboratories4$90
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$87
Amgen Inc.5$77
AstraZeneca Pharmaceuticals LP3$57
Exact Sciences Corporation1$18
Boehringer Ingelheim Pharmaceuticals, Inc.1$16

Products named: FREESTYLE LIBRE 3, XIFAXAN, Ozempic, AIRSUPRA, EVENITY, Rybelsus, REPATHA, The Cologuard Plus Collection Kit.

Industry payments across AL — which companies pay providers there.